Clinical Trials on Bacterium; Agent

Total 8254 results

Azidus Brasil

Unknown

Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis

Acute Bacterial Conjunctivitis

Brazil
Johns Hopkins Bloomberg School of Public Health
Brown University; National Institutes of Health (NIH); Universidad Peruana Cayetano... and other collaborators

Completed

Feasibility Intervention Trial of Two Types of Improved Cookstoves in Three Developing Countries

Respiratory Conditions Due to Other External Agents | Poisoning by Carbon Monoxide From Domestic Fuels

Kenya, Nepal, Peru
IVIEW Therapeutics Inc.

Completed

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis

Acute Bacterial Conjunctivitis

China
Bausch & Lomb Incorporated

Completed

A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis

Acute Bacterial Conjunctivitis
GlaxoSmithKline
Parexel

Completed

Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects

Infections, Bacterial

South Africa
GlaxoSmithKline

Withdrawn

A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions

Infections, Bacterial
GlaxoSmithKline

Completed

Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)

Infections, Bacterial

Germany
GlaxoSmithKline

Completed

WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics

Infections, Bacterial
Emergent BioSolutions
GlaxoSmithKline; Department of Health and Human Services; Centers for Disease...

Not yet recruiting

Clinical Benefit, Safety and PK of Raxibacumab in Subjects Exposed to Bacillus Anthracis

Infections, Bacterial
GlaxoSmithKline

Completed

To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.

Infections, Bacterial

United States
GlaxoSmithKline

Completed

Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions

Infections, Bacterial

South Africa
GlaxoSmithKline

Completed

To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects

Healthy Subjects | Infections, Bacterial

Australia
Emergent BioSolutions
GlaxoSmithKline

Completed

Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed

Infections, Bacterial

United States
Meyer Children's Hospital IRCCS

Recruiting

Epidemiological Study on Invasive Bacterial Diseases

Invasive Bacterial Diseases (IBD)

Italy
GlaxoSmithKline

Completed

A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose

Infections, Bacterial

United States
Merck Sharp & Dohme LLC

Completed

Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)

Arthroplasty, Replacement, Knee | Neuromuscular Blockade | Arthroplasty, Replacement, Hip | Blood Coagulation | Antithrombotic Agents
University Hospital Muenster
Hoffmann-La Roche

Terminated

MMF and Calcineurin Inhibitor Withdrawal in CAN

Kidney Failure, Chronic | Kidney Transplantation | Immunosuppressive Agents
NovaBay Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis (BACTOvation™)

Bacterial Conjunctivitis

United States
Alcon Research

Completed

An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients

Bacterial Conjunctivitis

China
Bausch & Lomb Incorporated

Completed

Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis

Bacterial Conjunctivitis
Merck Sharp & Dohme LLC

Completed

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

Bacterial Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle

Bacterial Conjunctivitis

United States
Alcon Research
Tufts University

Completed

Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora

Bacterial Conjunctivitis

United States
Allergan

Completed

A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States, Canada
Laboratorios Sophia S.A de C.V.

Completed

Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin) (Pazufloxacin)

Bacterial Conjunctivitis

Mexico
Kurobe LLC

Completed

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Alcon Research

Completed

Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis
Alcon Research

Completed

AL-15469A for the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Bausch & Lomb Incorporated

Terminated

Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Bausch & Lomb Incorporated

Terminated

Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Allergan

Completed

A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Alcon Research

Completed

AL-15469A for the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Laser Microsurgery Centre, Poland
Katedra I Klinika Okulistyki II Wydz. Lek. AM w Warszawie,; University Hospital... and other collaborators

Completed

Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis

Bacterial Conjunctivitis

Poland
Shire

Completed

Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo

Bacterial Conjunctivitis

United States, Australia, Austria, Israel, Poland, Hungary, South Africa, Canada, Estonia, France, Italy, Spain, Puerto Rico
Allergan

Completed

A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States, India
Beijing Tongren Hospital
Zhuhai Essex Bio-Pharmaceutical Company Limited; Panacea Technologies

Unknown

Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers

Bacterial Conjunctivitis

China
Merck Sharp & Dohme LLC

Completed

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)

Bacterial Conjunctivitis

United States
Alcon Research

Withdrawn

Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis
Alcon Research
Topical Solutions Ltd.

Completed

Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment

Bacterial Conjunctivitis

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer | Endometrial Cancer | Drug/Agent Toxicity by Tissue/Organ

United States
Massachusetts General Hospital
United States Agency for International Development (USAID)

Unknown

Thermal Images on Smartphones to Diagnose Bacterial Pneumonia in Children in Pakistan

Infections - Bacterial | Pneumonia - Bacterial

Pakistan
University of Pittsburgh
Celgene Corporation

Completed

Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit

Gram-negative Bacterial Infections

United States
Hospital Barros Luco Trudeau
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

Unknown

Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients

Gram Negative Bacterial Infections

Chile
Centro di Riferimento Oncologico - Aviano

Recruiting

Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA (MAGNETIC1)

Breast Neoplasms | Breast Diseases | Antineoplastic Agents | Aromatase Inhibitors | Neoplasms, Breast | Hormone Receptor Positive Breast Carcinoma | ESR1 Gene Mutation

Italy
Bayer

Completed

18850 - Human Photoallergy Test

Sunscreening Agents

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Lymphoma | Neurotoxicity | Radiation Toxicity | Cognitive/Functional Effects | Chemotherapeutic Agent Toxicity

United States, Israel
University of Pittsburgh
Merck Sharp & Dohme LLC

Withdrawn

Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates

Gram-negative Bacterial Infections

United States
Centre Hospitalier Universitaire de Besancon
University Hospital, Geneva; UMC Utrecht; University of Oxford; University Hospital... and other collaborators

Completed

Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities (MODERN)

Enterobacteriaceae Infections | Resistance Bacterial

France
Hoffmann-La Roche

Completed

A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants

Gram-negative Bacterial Infections

United States

Clinical Trials on Bacterium; Agent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations